SUNNYVALE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the…
CDC reports burden of six hard-to-treat superbugs increased by a combined 20% in 2021 and 2022 compared with 2019CDC call…
CHICAGO, July 30, 2024 /PRNewswire/ -- AliveDx, a global in vitro diagnostics company that aims to transform patient care, today…
HELSINKI, Finland, July 30, 2024 /PRNewswire/ -- DEEP Measures announces its collaborative platform to build digital measures in clinical trials,…
FREMONT, Calif., July 30, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of…
Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON, July 30, 2024 /PRNewswire/ --…
INDIANAPOLIS, ID / ACCESSWIRE / July 30, 2024 / 3Aware, a leader in real-time surveillance and data solutions for medical…
EIB offers Protembis venture debt for next-generation technology to reduce risk of brain injury in patients undergoing catheter-based heart treatment…
KANAZAWA, Japan, July 29, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, IMDEA Nanoscience (Madrid, Spain)…
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…